Overwhelming epidemiological evidence demonstrate that cardiovascular disease and
cancer represent major health burdens in the United States, and they are the leading causes …

Though not defined in detail, this discipline sees itself at the intersection of
oncology/haematology and cardiology, with a particular focus on mitigating and managing …

Cardiovascular disease (CVD) and cancer are the leading causes of death worldwide. With
an increasing number of the elderly population, and early cancer screening and treatment …

Cancer and cardiovascular diseases (CVDs) share many of the same risk factors. Using a
cloud-based health care database, we identified patients with malignancies that often …

The cardiovascular toxicity of cancer therapy has raised awareness of the importance of
heart disease in cancer care among oncologists and cardiologists, leading to the new …

An understanding of onco‐cardiology or cardio‐oncology is critical for the effective care of
cancer patients. Virtually all antineoplastic agents are associated with cardiotoxicity, which …

Cardiovascular disease (CVD) and cancer are the 2 leading causes of death worldwide.
Although commonly thought of as 2 separate disease entities, CVD and cancer possess …

The field of cardio-oncology was born from the necessity for recognition and management of
cardiovascular diseases among patients with cancer. This need for this specialty continues …

Improvements in early diagnosis and cancer treatments have contributed to high survival
rates for many cancer patients. However, these patients often die of cardiovascular disease …

Chemotherapy, radiotherapy, targeted therapy, and immunotherapy have brought hope to
cancer patients. With the prolongation of survival of cancer patients and increased clinical …